In breast cancer, IL-30 production in cancer and infiltrating leukocytes is associated with Triple Negative (TN) (which lacks estrogen- and progesterone-receptor expression and do not overexpress human epidermal growth factor receptor 2, HER2) and HER2+ molecular subtypes [16] (Figure 1a–c). Here, IL27 is linked to breast cancer.